Deep Plasma Proteomics-Based Diagnostic Panel for Early Detection of Amnestic Mild Cognitive Impairment
Journal of Proteome Research · 07.08.2026 · 25 (8) · 4237-4250
DOI: 10.1021/acs.jproteome.6c00231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 07.07.2026. Verfasst von Hui Shan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen518036, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Proteomics, Amnesia, Blood Proteins. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Foundation of Shenzhen City, National Natural Science Foundation of China, Shenzhen Municipal Fundamental Research Program.
Abstract (Originalsprache)
Amnestic mild cognitive impairment (aMCI) is often considered an early clinical stage of Alzheimer’s disease (AD), but its subtle presentation leads to infrequent neurological evaluations. Early plasma biomarker screening during routine check-ups in community hospitals could enhance aMCI detection rates. Advances in proteomics, particularly mass spectrometry, have enabled the detection of low-abundance plasma proteins, opening new possibilities for aMCI biomarker identification. This study included 84 participants from the STAR cohort. We utilized deep plasma proteomics to detect low-abundance proteins, enriched with nanoparticle magnetic beads. An early diagnostic model for aMCI was developed through bioinformatics and machine learning, with performance compared to the Simoa assay. We identified 4268 low-abundance plasma proteins and constructed a 12-protein diagnostic panel (AUC = 0.992 in the training set, AUC = 0.933 in the testing set), outperforming the Simoa assay (accuracy: 93.9% vs 24.4%). In conclusion, the 12-protein panel provides a cost-effective method for early aMCI detection, potentially improving screening efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen518036, China.
- Department of Medical Imaging, Peking University Shenzhen Hospital, Shenzhen518036, China.
- Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing100191, China.
- Central Laboratory, Peking University Shenzhen Hospital, Shenzhen518036, China.
- Department of Neurology, Peking University Shenzhen Hospital, Shenzhen518036, China.
ORCID-Profile: Gaigai Lu, Yuyao Yuan
Förderung
- Science and Technology Foundation of Shenzhen City
- National Natural Science Foundation of China
- Shenzhen Municipal Fundamental Research Program
- Shenzhen High-level Hospital Construction Fund
Zitieren
APA
Shan, H., Lu, G., Yuan, Y., Dong, Q., Fang, C., Yu, K., Chen, L., Wei, Z., Chen, H., Hu, L., Wu, T., Tao, S., Chen, Y., Luo, J., Qi, Y., Hu, J., Cheng, G., Fan, X., & Yin, Y. (2026). Deep Plasma Proteomics-Based Diagnostic Panel for Early Detection of Amnestic Mild Cognitive Impairment. Journal of Proteome Research, 25(8), 4237-4250. https://doi.org/10.1021/acs.jproteome.6c00231
Vancouver
Shan H, Lu G, Yuan Y, Dong Q, Fang C, Yu K, et al. Deep Plasma Proteomics-Based Diagnostic Panel for Early Detection of Amnestic Mild Cognitive Impairment. Journal of Proteome Research. 2026;25(8):4237-4250. doi:10.1021/acs.jproteome.6c00231
BibTeX
@article{Shan2026,
author = {Shan, Hui and Lu, Gaigai and Yuan, Yuyao and Dong, Qiongye and Fang, Chongzhou and Yu, Keyan and Chen, Lele and Wei, Zhuonan and Chen, Hui and Hu, Lin and Wu, Tong and Tao, Silin and Chen, Yunchen and Luo, Juan and Qi, Yulong and Hu, Jun and Cheng, Guanxun and Fan, Xiang and Yin, Yuxin},
title = {Deep Plasma Proteomics-Based Diagnostic Panel for Early Detection of Amnestic Mild Cognitive Impairment},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {8},
pages = {4237--4250},
doi = {10.1021/acs.jproteome.6c00231}
}
EUVIMED